Rola IL-13 w patogenezie idiopatycznego zespołu nerczycowego (IZN) u dzieci

• Authors: Pukajło - Marczyk Agnieszka , Zwolińska Danuta
• Languages of publication: PL

Keywords

PL

dzieci; nterleukina 13; idiopatyczny zespół nerczycowy

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2016
• Issue: 2
• Pages: 149-154

Contributors

author

Pukajło - Marczyk Agnieszka

author

Zwolińska Danuta

References

• A report of the International Study of Kidney Disease in Children. Nephrotic syndrome in children: prediction of histopathologyfrom clinical and laboratory characteristics at time of diagnosis. Kidney Int 1978; 13(2): 159–165.
• Cattran DC, Feehally J, Cook HT, et al. Kidney disease: improving global outcomes (KDIGO ) glomerulonephritis work group.KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2012; 2(2): 139–274.
• Habib R. A story of glomerulopathies: a pathologist’s experience. Pediatr Nephrol 1993; 7(4): 336–346.
• Shalhoub RJ . Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974; 2(7880): 556–560.
• Kim JE , Park SJ , Ha TS , et al. Effect of rituximab in MCNS : a role for Il-13 supression? Nat Rev Nephrol 2013; 9(9): 551
• Reiser J, Mundel P. Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome. J Am Soc Nephrol 2004; 15(9): 2246–2248.
• Wing K, Onishi Y, Prieto-Martin P, et al. CTL A-4 control over Foxp3+ regulatory T cell function. Science 2008; 322(5899):271–275.
• Reiser J, von Gersdorff G, Loos M, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004; 113(10): 1390–1397.
• Shimada M, Araya C, Rivard C, et al. Minimal change disease: a „two-hit” podocyte immune disorder? Pediatr Nephrol 2011;26(4): 645–649.
• Matsumoto K, Ohi H, Kanmatsuse K. Interleukin 10 and interleukin 13 synergize to inhibit vascular permeability factor release
• by peripheral blood mononuclear cells from patients with lipoid nephrosis. Nephron 1997; 77(2): 212–218.
• 11. Lai KW , Wei CL , Tan LK , et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc
• Nephrol 2007; 18(5): 1476–1485.
• 12. A R eport of the International Study of Kidney Disease in Children. Primary nephrotic syndrome in children: clinical significance
• of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int 1981; 20(6): 765–771.
• 13. Chapter 2: General principles in the management of glomerular disease. Kidney Int Suppl 2012; 2: 156–162.
• 14. Schwartz GJ , Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CK D. J Am Soc Nephrol 2009;
• 20(3): 629–637.
• 15. Kapp U, Yeh WC , Patterson B, et al. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg
• cells. J Exp Med 1999; 189(12): 1939–1946.
• 16. Skinnider BF, Kapp U, Mak TW . Interleukin 13: A growth factor in Hodgkin lymphoma. Int Arch Allergy Immunol 2001; 126(4):
• 267–276.
• 17. Tain YL , Chen TY , Yang KD. Implications of serum TN F-beta and IL -13 in the treatment response of childhood nephrotic syndrome.
• Cytokine 2003; 21(3): 155–159.
• 18. Mishra OP, Teli AS, Singh U, et al. Serum immunoglobulin E and interleukin-13 levels in children with idiopathic nephrotic
• syndrome. J Trop Pediatr 2014; 60(6): 467–471.
• 19. Cheung W, Wei CL , Seah CC , et al. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Pediatr
• Nephrol 2004; 19(6): 627–632.
• 20. Yilmaz D, Yenigün A, Sönmez F, et al. Evaluation of children with steroid-sensitive nephrotic syndrome in terms of allergies.
• Ren Fail 2015; 37(3): 387–391, doi: 10.3109/0886022X.2014.996087.
• 21. Jiang HK, Jiang H, Luo G, et al. Interleukin-13 expression before and after pulse treatment with methylprednisolone in children
• with steroid-responsive nephrotic syndrome. Chin J Contemp Pediatr 2007; 9(6): 533–536.